Clinic
Family Medical Clinic of Trezevant
Family Medical Clinic of Trezevant was paid $1.51M by Medicaid between Dec 2019 and Dec 2024, across 53 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 52% of everything it billed.
33Billing provider infoFAMILY MEDICAL CLINIC OF TREZEVANT
TREZEVANT, TN 38258
TREZEVANT, TN 38258
33aNPI1538703897assigned 10/30/2019
33bProvider typePrimary Care Clinic/Center
28Total paid$1.51M
24GClaims150,919
24DCodes billed53
24AFirst – last monthDec 2019 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Tennessee
Rank by total paid#14 of 139
Median peer was paid$101K
This provider vs. median15×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 207 | $574.02 | |
| 2020 | 6,179 | $149K | |
| 2021 | 18,102 | $332K | |
| 2022 | 38,267 | $379K | |
| 2023 | 50,637 | $402K | |
| 2024incomplete | 37,527 | $245K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 52% | 17,480 | 13,758 | $785K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 10,508 | 8,197 | $326K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.0% | 2,496 | 2,119 | $75K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.3% | 1,200 | 937 | $65K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.4% | 4,111 | 3,042 | $51K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.2% | 2,168 | 1,687 | $33K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.1% | 3,593 | 3,106 | $31K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.8% | 424 | 357 | $27K |
| 80305 | 1.1% | 3,211 | 2,508 | $16K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 288 | 258 | $14K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 659 | 549 | $14K |
| 96160 | <1% | 1,290 | 989 | $13K |
41 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 722 | $12K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 90 | $6K |
| 92552 | <1% | 420 | $6K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 154 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,111 | $4K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 719 | $4K |
| 99173 | <1% | 837 | $4K | |
| 96127 | <1% | 1,141 | $3K | |
| 81003 | <1% | 2,076 | $3K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 29 | $2K |
| 81025 | <1% | 300 | $1K | |
| 99384 | <1% | 13 | $1K | |
| 85018 | <1% | 493 | $930.01 | |
| 92551 | <1% | 141 | $911.56 | |
| 99358 | Prolong nursin fac eval 15m | <1% | 32 | $833.90 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 494 | $824.77 |
| 36416 | <1% | 345 | $561.01 | |
| 3079F | <1% | 2,680 | $421.09 | |
| 3074F | <1% | 8,604 | $390.72 | |
| 3078F | <1% | 7,801 | $390.70 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 870 | $330.86 |
| 99408 | <1% | 59 | $327.59 | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 20 | $264.83 |
| 3077F | <1% | 878 | $200.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 54 | $163.79 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 106 | $155.85 |
| 93000 | <1% | 20 | $139.76 | |
| 3080F | <1% | 389 | $120.00 | |
| 3075F | <1% | 1,040 | $120.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 17 | $97.98 |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 26 | $52.49 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 46 | $47.55 |
| 2001F | 0% | 16,239 | $0.00 | |
| 3008F | 0% | 17,070 | $0.00 | |
| 2010F | 0% | 17,350 | $0.00 | |
| 2000F | 0% | 15,646 | $0.00 | |
| 99000 | 0% | 3,268 | $0.00 | |
| 3044F | 0% | 67 | $0.00 | |
| 2030F | 0% | 82 | $0.00 | |
| 4120F | 0% | 16 | $0.00 | |
| G9584 | Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEGGETT, DEBORAH (OWNER)